ursodeoxycholic acid has been researched along with Carcinoma, Epidermoid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Descourt, R; Fouchard, M; Jantzem, H; Poureau, PG; Quere, G; Robinet, G | 1 |
| Deng, J; Liu, W; Pang, L; Qiu, L; Tan, X; Zhao, X | 1 |
2 other study(ies) available for ursodeoxycholic acid and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Three cases of immune cholangitis related to anti-programmed cell death and programmed cell death ligand agents for the treatment of non-small cell lung cancer.
Topics: Adenocarcinoma of Lung; Adrenal Cortex Hormones; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents, Immunological; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cholagogues and Choleretics; Cholangitis; Humans; Lung Neoplasms; Male; Middle Aged; Nivolumab; Treatment Outcome; Ursodeoxycholic Acid | 2019 |
Anticancer Effect of Ursodeoxycholic Acid in Human Oral Squamous Carcinoma HSC-3 Cells through the Caspases.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Caspases; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme Activation; Head and Neck Neoplasms; Humans; Inhibitor of Apoptosis Proteins; NF-kappa B; Receptors, TNF-Related Apoptosis-Inducing Ligand; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck; Ursodeoxycholic Acid | 2015 |